Loading…
Import this data to Google Sheets with:
=jivedata("DBVTF","financials")Full statements spill as a table. For one cell: =jivedata("DBVTF","Revenue") or =jivedata("DBVTF","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
DBVTF • CIK 0001613780
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $15,728 | $4,151 | $5,636 | $5,019 |
| Operating Income (Loss) | $-76,432 | $-116,589 | $-147,056 | $-177,828 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $-72,719 | $-113,863 | $-146,456 | $-175,219 |
| Income Tax Expense (Benefit) | $7 | $55 | $491 | $774 |
| Net Income (Loss) Attributable to Parent | $-72,726 | $-113,918 | $-146,947 | $-175,993 |
| Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | $5,710 | $-4,222 | $7,170 | $-6,025 |
| Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax | $-38 | $163 | $-408 | $-364 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $-67,054 | $-117,977 | $-140,185 | $-182,382 |
| Weighted Average Number of Shares Outstanding, Basic | 95,121,390 | 96,995,379 | 139,574,259 | 445,616,358 |
| Research and Development Expense | $60,223 | $89,342 | $116,682 | $126,106 |
| Selling and Marketing Expense | $2,438 | $2,659 | $3,222 | $12,941 |
| General and Administrative Expense | $29,500 | $28,739 | $32,788 | $43,799 |
| Operating Expenses | $92,161 | $120,740 | $152,692 | $182,846 |
| Net Income (Loss) Available to Common Stockholders, Diluted | — | $-113,918 | $-146,947 | $-175,947 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 |
|---|
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $-72,726 | $-113,918 | $-146,947 | $-175,993 |
| Net Cash Provided by (Used in) Operating Activities | $-79,653 | $-104,474 | $-121,181 | $-169,308 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | $5,867 | $-4,268 | $8,080 | $-5,266 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-67,827 | $-108,913 | $161,711 | $71,759 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $141,367 | $32,456 | $194,167 | $410,405 |
| Share-based Payment Arrangement, Noncash Expense | $6,019 | $4,620 | $5,387 | $8,440 |
| Inventory Write-down | — | — | $16,062 | $11,411 |
| Other Noncash Income (Expense) | $-23 | $3 | $219 | $1,121 |
| Payments to Acquire Property, Plant, and Equipment | $677 | $2,338 | $532 | $1,290 |
| Payments to Acquire Intangible Assets | $0 | — | $6 | $6 |
| Net Cash Provided by (Used in) Investing Activities | $-808 | $-757 | $-1,369 | $-1,856 |
| Proceeds from Issuance or Sale of Equity | $6,921 | $634 | $275,706 | $247,784 |
| Net Cash Provided by (Used in) Financing Activities | $6,767 | $587 | $276,182 | $248,190 |
| Increase (Decrease) in Inventories | $0 | — | $16,062 | $11,362 |
| Increase (Decrease) in Other Current Assets | $3,795 | $-4,629 | $4,699 | $9,742 |
| Increase (Decrease) in Accounts Payable, Trade | $8,420 | $272 | $15,783 | $462 |
| Increase (Decrease) in Other Operating Liabilities | $-5,334 | — | $6,521 | $6,448 |